Notably, simultaneous KrasG12D expression and Nkx2-1 inactivation induces mucinous-type lung adenocarcinomas, whereas KrasG12D expression alone induces only non-mucinous type lung adenoma/adenocarcinomas. Here, NKX2-1 is linked to lung adenocarcinoma.